Autopsy report · NCT01105884
Clinical and Cost Effectiveness of Different Dressing Materials in Diabetic Foot Ulcers
Cause of deathStaffing, sites or logistics
“Due to administrative reason”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- M.V. Hospital for Diabetes
- Sponsor type
- University, hospital or other
- Conditions
- Diabetic Foot Ulcers
- Interventions
- Normal Saline; Biatin Ag (Foam); Hydrocolloid; Hydrogel; Ceredak
- Participants
- 0
- Sites
- 1
- Countries
- India
Trials that died the same way
- A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
“Due to administrative reasons” - Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
“Administrative reasons.” - Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
“Due to business reasons” - The Effect of Sodium Bicarbonate (Nephrotrans®) on Calcification Propensity of Serum in Kidney Transplant Recipients
“due to organizational reason” - An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
“Administrative Reason”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.